Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Clinical Trial for Ovarian Cancer (OvaRex®)

ClinicalTrials.gov ID: NCT00050375

Public ClinicalTrials.gov record NCT00050375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Study identification

NCT ID
NCT00050375
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Unither Pharmaceuticals
Industry
Enrollment
354 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2002 (Type not available)
Primary completion
Not listed
Completion
Dec 2007 (Actual)
Last update posted
Dec 18, 2007

2002 – 2007

United States locations

U.S. sites
62
U.S. states
30
U.S. cities
57
Facility City State ZIP Site status
Comprehensive Cancer Institute Huntsville Alabama 35801 —
Western Regional Community Clinical Oncology Program Phoenix Arizona 85006 —
Little Rock Hematology Oncology Assoc. Little Rock Arkansas 72205 —
St. Jude Medical Center Fullerton California 92835 —
Wilshire Oncology Medical Group La Verne California 91750 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
UCLA School of Medicine Los Angeles California 90095-1740 —
Gynecologic Oncology Associates Newport Beach California 92663 —
University of California, Irvine Orange California 92868 —
Sharp Memorial Hospital San Diego California 92123 —
Stanford University Stanford California 94305 —
Rocky Mountain Cancer Center-Midtown Denver Colorado 80218 —
University of Connecticut Cancer Center Farmington Connecticut 06030 —
Northwestern Connecticut Oncology Hematology Associates, LLP Torrington Connecticut 06790 —
Florida Gynecologic Oncology Fort Myers Florida 33901 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
Pensacola Research Consultants Pensacola Florida 32504 —
H. Lee Moffitt Cancer Center and Research Tampa Florida 33612-9497 —
Medical College of Georgia Augusta Georgia 30912 —
The University of Chicago Hospitals Chicago Illinois 60637 —
St. Vincent Gynecologic Oncology Indianapolis Indiana 46260 —
Michiana Hematology Oncology PC South Bend Indiana 46617 —
Brown Cancer Center Louisville Kentucky 40202 —
Louisville Oncology Louisville Kentucky 40202 —
Lake Charles Medical Surgical Clinic Lake Charles Louisiana 70601 —
Hematology and Oncology Specialists New Orleans Louisiana 70115 —
The Harry and Jeanette Weinberg Cancer Institute Baltimore Maryland 21237-3998 —
New England Medical Center Boston Massachusetts 02111 —
Women's Specialty Center Jackson Mississippi 39202 —
Ellis Fischel Cancer Center Columbia Missouri 65203 —
Jersey Shore Medical Center Neptune City New Jersey 07754 —
North Shore University Hospital Manhasset New York 11030 —
St. Vincent's Comprehensive Cancer Center New York New York 10011 —
Nyack Hospital Nyack New York 10960 —
SUNY-HSC Syracuse, Crouse Hospital Syracuse New York 13210 —
Blumenthal Cancer Center Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27710 —
University Hospital - Health Systems Cleveland Ohio 44106 —
GYN Oncology and Pelvic Surgery Associates Columbus Ohio 43222 —
ProMedica Health Systems Toledo Ohio 43606 —
Medical College of Ohio Cancer Institute Toledo Ohio 43614-5809 —
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104 —
Northwest Cancer Specialists-Northrup Portland Oregon 97210 —
Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Brown University School of Medicine Providence Rhode Island 02905 —
South Carolina Oncology Associates Columbia South Carolina 29203 —
Gynecologic Oncology Research and Development Greenville South Carolina 29601 —
Chattanooga GYN Oncology Chattanooga Tennessee 37403 —
West Clinic, PC Memphis Tennessee 38120 —
Arlington Cancer Center Arlington Texas 76012 —
Southwest Regional Cancer Center Austin Texas 78705 —
Univ. of Texas SW Medical Center at Dallas Dallas Texas 75235-9032 —
Texas Oncology, PA Dallas Texas 75246-2006 —
Texas Oncology Fort Worth Texas 76104 —
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
University of Virginia Cancer Center Charlottesville Virginia 22908 —
VA Oncology Associates Norfolk Virginia 23502 —
Carilion GYN Oncology Associates Roanoke Virginia 24014 —
Swedish Medical Center Seattle Washington 98104 —
Cancer Care Northwest Spokane Washington 99218 —
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00050375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2007 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00050375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →